Position in DYN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$825,767
+$162,772 QoQ
Shares Held
37,180
+1.7% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#128
of 245 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Derivatives in DYN
reported options exposure · as of Dec 31, 2025CallValue
$0
CallShares
0
PutValue
$1,238,148
PutShares
63,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,706,205,847 across 455 Biotechnology names. DYN ranks #125 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
733,274 | $364,239,192 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,192 | $159,745,957 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
1,603,136 | $127,112,653 | |
| 4 | ARGX |
Argenx SE
|
134,427 | $124,717,337 | |
| 5 | MRNA |
Moderna, Inc.
|
1,035,126 | $72,489,872 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
714,423 | $53,210,224 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
957,848 | $52,624,168 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
431,753 | $42,087,281 |
All Filings in DYN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $825,767 | 37,180 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $662,995 | 36,569 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,238,148 | 63,300 | Put | Sole | 2026-02-13 | |
| 2025-12-31 | $8,775,749 | 448,658 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $800,745 | 63,300 | Put | Sole | 2026-03-31 | |
| 2025-09-30 | $6,080,866 | 480,701 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $3,051,064 | 320,490 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $2,418,603 | 231,224 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $4,529,150 | 192,239 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $7,446,539 | 207,309 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $2,790,133 | 79,063 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $2,383,965 | 83,972 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $2,039,568 | 153,351 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $892,183 | 99,574 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $922,173 | 81,971 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $369,653 | 32,088 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $280,976 | 24,243 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $216,903 | 17,079 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $546,158 | 79,499 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $184,953 | 19,186 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||